GRIFOLS reported EUR2.04B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Alcon AG USD 2.72B 60M Sep/2026
Almirall EUR 602.71M 55.09M Jun/2026
Amadeus IT EUR 1.74B 90M Sep/2026
Amarin USD 49.22M 451K Dec/2025
argenx SE USD 1.72B 361M Sep/2026
AstraZeneca USD 16.21B 830M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
Cie Automotive EUR 1.05B 908.2M Mar/2026
Demant DKK 6.67B 420M Jun/2026
Ence Energia y Celulosa EUR 215.89M 61.99M Sep/2026
Essilor EUR 14.82B 351M Jun/2026
Ferrovial EUR 2.6B 113M Jun/2026
Fresenius EUR 5.88B 70M Sep/2026
Fresenius Medical Care EUR 4.94B 80M Sep/2026
Genmab DKK 1.16B 259M Jun/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
GRIFOLS EUR 2.04B 170M Sep/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Inditex EUR 11B 2.26B Jun/2026
Lakefront Biotherapeutics EUR 7.11M 5M Sep/2026
Merck EUR 5.63B 200M Sep/2026
Novartis USD 14.52B 112M Sep/2026
Philips EUR 4.4B 40M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 14.44B 2.49B Sep/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
UCB EUR 4.25B 764M Dec/2025
Viscofan EUR 336M 11M Sep/2026